- Open Access
Visualization of spatiotemporal dynamics of human glioma stem cell invasion
Molecular Brain volume 12, Article number: 45 (2019)
Glioblastoma exhibits phenotypic and genetic heterogeneity, aggressive invasiveness, therapeutic resistance, and tumor recurrence, which can be explained by the existence of glioma stem cells (GSCs). In this study, we visualized the spatiotemporal dynamics of invasion of human GSCs in an orthotopic xenograft mouse model using time-lapse imaging of organotypic brain slice cultures and three-dimensional imaging of optically cleared whole brains. GSCs implanted in the striatum exhibited directional migration toward axon bundles, perivascular area, and the subventricular zone around the inferior horn of the lateral ventricle. GSCs migrated in a helical pattern around axon bundles in the striatum and invaded broadly in both the rostral and caudal directions. GSCs in the corpus callosum migrated more rapidly and unidirectionally toward the contralateral side with pseudopod extension. These characteristics of GSC invasion shared histological features observed in glioblastoma patients. Spatiotemporal visualization techniques can contribute to the elucidation of the mechanisms underlying GSC invasion that may lead to the development of effective therapy for glioblastoma.
Glioblastoma is the most common and aggressive form of primary brain tumors  and exhibits a high degree of phenotypic and genetic heterogeneity . Complete surgical removal of tumor cells is difficult because glioblastoma frequently invades across the corpus callosum resulting in bi-hemispheric lesions that have a “butterfly” appearance. The current standard treatment following surgical resection, which includes radiotherapy and chemotherapy with temozolomide, provides only a modest survival benefit .
The presence of glioma stem cells (GSCs) that have self-renewal and tumor-initiating capacity has been demonstrated [4,5,6]. GSCs are thought to be an underlying cause of therapeutic resistance and tumor recurrence [7,8,9]. Therefore, molecular markers that identify GSCs may be a key for the development of therapeutic approaches targeting GSCs. While many putative GSC molecular markers, including CD133 and nestin, have been identified, they are inconsistent and cannot universally define GSCs due to remarkably high intertumoral and intratumoral heterogeneity .
Xenograft-based animal models of glioblastoma are invaluable for the study of the biology of human glioblastoma in vivo and for the evaluation of therapeutic effects . An orthotopic xenograft mouse model has been widely used with human glioblastoma cell lines, such as U87 and U251. However, non-invasive tumor mass is formed and the tumor margin is clearly defined in these xenografts, which do not display the histopathological features of glioblastoma [12,13,14,15]. In contrast, xenografts generated by the transplantation of biopsies or GSCs from patients with glioblastoma recapitulate both the genetic and histological features of the primary tumor [11, 16, 17]. Recently, we have isolated GSCs from human glioblastoma specimens . These established cell lines, including hG008, have the potential of high tumorigenesis and aggressive invasiveness.
Visualization techniques have been developed for brain images at high resolution. The organotypic brain slice culture system, which is ideally suited for temporal analysis, serve as a valuable ex vivo tool for various fields of neuroscience [19,20,21,22,23], although global visualization is difficult. For spatial analysis, tissue-clearing methods enable three-dimensional (3D) imaging of whole brain with cellular resolution [24,25,26,27]. Here, we report for the first time the spatiotemporal characterization of human GSC invasion in an orthotopic xenograft mouse model using time-lapse imaging of organotypic brain slice cultures and 3D imaging of optically cleared whole brains.
The human glioblastoma cell line U87 was obtained from the American Type Culture Collection. U87 cells were cultured in DMEM (Sigma-Aldrich, St. Louis, MO, USA) containing 10% fetal bovine serum, 2 mM L-glutamine, 100 units/mL penicillin, and 100 μg/mL streptomycin. The human GSC line hG008 was established from human glioblastoma specimens (Additional file 1) . Written informed consent was obtained from the patient. hG008 cells were cultured in Ultra-Low attachment cell culture flasks (Corning, Kennebunk, ME, USA) in DMEM/Ham’s F-12 with HEPES (Wako, Osaka, Japan) containing 2% B-27 (Thermo Fisher Scientific, Waltham, MA, USA), 20 ng/mL recombinant human fibroblast growth factor-basic (PeproTech, Rocky Hill, NJ, USA), 20 ng/mL recombinant human epidermal growth factor (PeproTech), 1000 units/mL recombinant human leukemia inhibitory factor (Nacalai Tesque, Kyoto, Japan), and 1 unit/mL heparin.
U87 cells and hG008 cells were transduced with the lentiviral vector CSII-EF-ffLuc containing the ffLuc gene (a Venus fluorescent protein  and firefly luciferase fusion gene) under the control of human elongation factor 1 α subunit (EF-1α) promoter . Transduced cells were seeded as single cells into a 96-well plate and expanded. Single-cell clones stably expressing ffLuc were established.
Female BALB/c nude mice (20 g, 6 weeks old) (Sankyo Labo Service Corporation, Tokyo, Japan) were anesthetized with equithesin and placed in a stereotaxic apparatus (Narishige Scientific Instrument Lab, Tokyo, Japan). U87 cells or hG008 cells (1 × 105 cells in 2 μL of phosphate-buffered saline (PBS)) were implanted in the right striatum using a 10-μL Hamilton syringe to a depth of 3 mm from the brain surface through the burr hole 2 mm lateral to the bregma. U87 cells were also implanted in the right cortical area, subventricular zone, or corpus callosum for organotypic brain slice culture. All experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of Keio University (Approval number: 14057) and the Guide for the Care and Use of Laboratory Animals (National Institutes of Health (NIH), Bethesda, MD, USA).
Mice were sacrificed and transcardially perfused with 4% paraformaldehyde (PFA) at the indicated time points. Brain tissues were fixed with 4% PFA followed by cryoprotection by soaking in 10 and 20% sucrose at 4 °C overnight. Twenty-μm thick coronal sections were cut with a REM-700 microtome (Yamato Kohki, Saitama, Japan). Sections were stored in sterile antifreeze solution at − 20 °C .
Organotypic brain slice culture and image analysis
At 7 days (U87) or 45 days (hG008) after implantation, brain tissues were obtained without perfusion and were sliced into 200-μm thick sections using a Vibratome (Leica, Wetzlar, Germany). The corticostriatal slices containing U87 cells or hG008 cells were placed on Millicell cell culture insert (PICM0RG50; Merck KGaA, Darmstadt, Germany) and transferred to a 3.5-cm glass-bottom dish with 1.8 mL of culture medium. Time-lapse imaging of slice cultures was performed using a confocal laser scanning microscope FV10 (Olympus, Tokyo, Japan), equipped with a temperature and gas supply control system. Images were captured every 20 min during the 144-h culture period, and the photo-bleaching effect was not observed. Image processing was performed using Xcellence software (Olympus). Other serial slices were fixed with 4% PFA every 12 h for 144 h and embedded into paraffin blocks for mutually synchronized histopathological analysis.
3D cell tracking was performed using Imaris image analysis software (Bitplane, Zurich, Switzerland), and tracks were generated based on the Z-stacks of time-lapse confocal fluorescent images. The cell migration tracks were quantitatively parameterized in terms of several metrics. Migration speed, direction, and distance connecting the start and end of the cell tracks were measured, because the cell migratory behavior was further characterized using those three indices. The length of pseudopod was quantified with ImageJ software (NIH) from 2D projections of the imaged volume.
In vivo bioluminescence imaging
A Xenogen-IVIS 100 imaging system (PerkinElmer, Waltham, MA, USA) was used for in vivo bioluminescence imaging (BLI). Tumor growth was monitored once per week after implantation. Mice anesthetized with isoflurane gas were intraperitoneally injected with 300 mg/kg D-luciferin (VivoGlo Luciferin; Promega, Madison, WI, USA) and placed on a warmed stage inside the camera box of the IVIS imaging system coupled with cool CCD camera using software v2.5. Images were quantified as photons per second for U87 cells, and per minute for hG008 cells.
Mice were perfused with 4% PFA at 45 days after implantation of hG008 cells. For preparation of PASSIVE CLARITY-processed mouse brains, brain tissues were fixed with 4% PFA at 4 °C overnight and then incubated in hydrogel solution (4% PFA, 4% acrylamide, 0.25% VA044 in PBS) at 4 °C for 3 days . Brain tissues were degassed and polymerized in the same hydrogel solution at 37 °C for 3 h. Four-mm thick coronal sections, except cerebellum and olfactory bulb, were cut. Hydrogel-embedded tissue sections were washed with clearing solution (200 mM sodium borate buffer (pH 8.5) containing 4% SDS) at 37 °C with shaking for 2 h. Sections were then incubated in fresh clearing solution at 48 °C for 5 days. Imaging was performed by multi-photon microscopy (FLUOVIEW FVMPE-RS; Olympus) and 3D images were reconstructed using FV31S-SW software with a maximum intensity projection algorithm (Olympus).
For immunocytochemistry, cells were plated on 12-mm cover slips coated with poly-L-lysine or poly-L-ornithine/fibronectin-coated chamber slides. The cultured cells were fixed with 4% PFA and permeabilized with 0.5% Triton-X. For immunohistochemistry, 3-μm paraffin-embedded tissue sections from slice cultures and 20-μm tissue sections from in vivo experiments were used. Samples were stained with the following primary antibodies (diluted 1:200): anti-NeuN (mouse IgG1; MAB377, Merck KGaA), anti-GFAP (rat IgG2a; 13–0300, Thermo Fisher Scientific), anti-O4 (mouse IgM; MAB345, Merck KGaA), anti-human Nestin (rabbit IgG; 18741, Immuno-Biological Laboratories, Gunma, Japan), anti-human Neurofilament protein (mouse IgG1; IS607, DAKO, Glostrup, Denmark), and anti-mouse CD31 (rat IgG2a; 550274, BD Biosciences, Tokyo, Japan). The primary antibodies were detected using Alexa Fluor 555-, Alexa Fluor 568-, or Alexa Fluor 647-conjugated secondary antibodies (diluted 1:500) (Thermo Fisher Scientific). Samples were mounted with VECTASHIELD Antifade Mounting Medium containing DAPI (Vector Laboratories, Burlingame, CA, USA) and examined by fluorescence microscopy (BZ-9000 Biorevo; Keyence, Osaka, Japan). Histological characteristics were assessed using hematoxylin and eosin (H&E) staining.
Student’s t-test was used to compare the speed and distance of cell migration between U87 and hG008 cells. One-way ANOVA followed by post-hoc test was used to compare the speed and direction of cell migration and the length of pseudopod in different brain areas. Statistical analyses were performed with IBM SPSS statistics (IBM, Armonk, NY, USA). A P-value of < 0.05 was considered statistically significant.
In vitro and in vivo growth characteristics of U87 cells and hG008 cells
To compare the invasive characteristics, a non-invasive human glioblastoma cell line U87 was used as a negative control. U87 cells expressing ffLuc were grown as monolayers in vitro (Fig. 1a). In the brains of mice implanted with 1 × 105 U87 cells in the striatum, a clear delineation of the tumor margin was identified by H&E staining at 21 days after implantation (Fig. 1b). The invasion of U87 cells across the corpus callosum was not observed by Venus fluorescence (Fig. 1c), which was like a metastatic tumor in the human brain. All implanted mice died within 30 days after implantation (Fig. 1d). Tumor was macroscopically observed in the brain (Fig. 1e). Luciferase-based BLI using the IVIS system showed one large peak (Fig. 1e), which was consistent with the fluorescence image of Venus (Fig. 1c).
The human GSC line hG008 expressing ffLuc had a sphere-forming capacity (Fig. 1f), but the cell proliferation rate was not different from that of U87 cells. In the brains of mice implanted with 1 × 105 hG008 cells, diffuse invasion with extensive unclear margin was identified by H&E staining at 45 days after implantation. (Fig. 1g). The invasion of hG008 cells across the corpus callosum was observed by Venus fluorescence, resulting in bi-hemispheric lesions that had a winged-like appearance (Fig. 1h). The tumor invasion was similar to the histological features of glioblastoma patients. All implanted mice progressively weakened and died 2–3 months after implantation (Fig. 1i). It was difficult to macroscopically distinguish tumor from normal cells (Fig. 1j). BLI showed two peak signals, which reflected the winged-like appearance (Fig. 1j).
Time-lapse imaging of organotypic brain slice culture
Since U87 cells form non-invasive tumor mass, U87 cells were implanted in the striatum, cortical area, subventricular zone, or corpus callosum. Time-lapse imaging of organotypic brain slice cultures showed that U87 cells formed a large mass structure in all implanted areas (Fig. 2a, Additional file 2). A few U87 cells invaded from the tumor core. U87 cells implanted in the corpus callosum migrated randomly, and no directional preference was observed (Fig. 2a).
In contrast, time-lapse imaging of slice cultures revealed the highly invasive characteristics of hG008 cells in different brain areas (Additional files 3, 4, 5 and 6). In the striatum, where hG008 cells were implanted, hG008 cells diffusely invaded (Fig. 2b). In the cortical area, hG008 cell density was low for 144 h. Around inferior horn of the lateral ventricle, hG008 cells tended to invade toward the wall of the ventricle. In the corpus callosum, hG008 cells migrated predominantly in one direction with a to-and-fro motion. Once hG008 cells entered into the space of corpus callosum, they rarely exited (Fig. 2b). There was no significant difference in migration speed between U87 cells and hG008 cells, while the distance between the start and end points of hG008 cells was longer than that of U87 cells (Fig. 2c).
The migration speed of hG008 cells in the corpus callosum was the fastest among three areas analyzed (Fig. 3a). The migration direction of hG008 cells in the corpus callosum exhibited a uniform direction compared with that in other areas (Fig. 3a). During the 144-h observation period, hG008 cells underwent cell division several times in all analyzed areas including the contralateral side. During cell division, the migration temporarily stopped, then two daughter cells migrated in the reverse direction (Fig. 3b). At the moment of cell division, daughter cells rebounded off each other, leading to the fastest movement (Fig. 3c). In the striatum, hG008 cells migrated along axon bundles (Fig. 3d). hG008 cells exhibited longer pseudopods at the moment of migration compared with U87 cells. The length of pseudopod of hG008 cells was the longest in the corpus callosum (Fig. 3e).
Differentiation of GSCs
hG008 cells have the ability to differentiate into cells of astroglial, neuronal, and oligodendroglial lineages in vitro . Under the serum-free sphere-forming culture condition, hG008 cells expressed Nestin, a neural stem/progenitor cell marker, but neural differentiation markers, GFAP, O4, and NeuN, were not expressed (Fig. 4a).
Immunostaining of brain slice cultures showed a few GFAP-positive hG008 cells at the implanted striatum, indicating astrocytic differentiation (Fig. 4b). However, no GFAP-positive hG008 cells were observed in other areas (Fig. 4c, d). No hG008 cells expressing O4 or NeuN were detected. Most hG008 cells invading to various arias expressed Nestin (Fig. 4b, c, d), suggesting that hG008 cells retained stemness during migration.
Directional migration of GSCs
Immunohistochemical analysis was performed on brain sections from mice implanted with hG008 cells. hG008 cells migrated along axonal fibers, as visualized by immunostaining for neurofilament protein, in the striatum, corpus callosum, and cingulate gyrus (Fig. 5a). Of note, most hG008 cells in the corpus callosum migrated unidirectionally, and hG008 cells were rarely identified outside the corpus callosum (Fig. 5a). hG008 cells exhibited strong directional migration toward the inferior horn of the lateral ventricle in comparison to the body of the lateral ventricle, and H&E staining demonstrated that hG008 cells were concentrated around the inferior horn (Fig. 5b). Moreover, hG008 cells were observed around GFAP-positive mouse cells attaching the wall of the inferior horn. hG008 cells were often found in the perivascular area of large-sized blood vessels (Fig. 5c).
3D imaging of GSCs using whole-brain clearing
Brain tissues at 45 days after implantation of hG008 cells were optically cleared, and 3D fluorescence images of the striatum, cortical areas, inferior horn of the lateral ventricle, and corpus callosum were obtained (Fig. 6a, Additional files 7, 8, 9 and 10). 3D images of the striatum revealed that hG008 cells migrated in a helical pattern, twisting around axon bundles. The diameter of helical movement was approximately 100 μm, which was similar to that of axon bundles in the striatum (Fig. 6b). This was consistent with the results of brain slice cultures (Fig. 3d). In the cortical area, tumor cell density was low, and migration along the anteroposterior axis (the Z-axis) was rarely detected (Fig. 6c). 3D images of the subventricular zone of the inferior horn showed migration toward the inferior horn from all directions (Fig. 6d). 3D images of the corpus callosum confirmed unidirectional migration (Fig. 6e). These invasion patterns are summarized in the scheme shown in Fig. 6f.
Although invasion of GSCs in a living organism has been previously reported by using time-lapse imaging of brain slice cultures, only a small area around the implanted site was analyzed [19, 20]. Recently, 3D brain imaging has been obtained using the tissue-clearing method, in which the architecture of neural circuits has been clearly identified [24, 26, 27]. In the present study, using time-lapse imaging of organotypic brain slice cultures and 3D imaging of optically cleared whole brains, the invasion of human hG008 GSCs was spatiotemporally visualized in multiple brain areas.
Non-invasive glioma cells, such as U87 cells, migrate in a fibroblast-like manner, extending a broad lamellipodium [31, 32]. In contrast, GSCs migrate like neural progenitor cells (NPCs) with a mesenchymal mode of motility, in which a leading portion of polarized cell extends forward and movement is a traction-dependent manner [31, 33,34,35]. The focal adhesions to the extracellular matrix (ECM) that recruit ECM-degrading proteolytic enzymes lead to ECM remodeling and generation of corridors for migration. hG008 GSCs showed the longest pseudopod and rapid migration in the corpus callosum. Before cell division, hG008 cells temporarily squeezed, then daughter cells rebounded off each other with the fastest movement. These observations add new information to the characteristics of GSC migration. As demonstrated in this study, glioma cells are known to reside in perivascular spaces . Invasive glioma cells change the morphology of peritumoral microvessels by inducing intussusceptive microvascular growth and capillary loop formation, which may be beneficial for glioma growth .
Glioma cells are known to invade along white matter tracts , which are suggested to contain chemoattractants. Neurofilament, a neuronal intermediate filament essential for the radial growth of axons during development, was used to detect axon bundles . GSC migration along axon bundles was shown in the striatum by immunostaining for neurofilament protein. This directional preference was made even clearer by the analysis of Z-axis component obtained by 3D imaging of cleared whole brains. GSCs migrated in a helical pattern around axon bundles, leading to invasion in both the rostral and caudal directions from the implanted area.
Directional migration of GSCs may be associated with the anatomic features. The corpus callosum, composed of callosal axons, is the major commissural tract connecting the cortical regions of the right and left hemispheres. Thin fibers are observed in the anterior corpus callosum (genu), and the large myelinated fibers are preferentially located in the posterior region (splenium) [38, 39]. Since our results demonstrate that GSCs tend to migrate toward the anterior corpus callosum rather than posterior lesion with the fastest moving speed and almost all GSCs do not divagate from the corpus callosum, the axonal density may be associated with the direction and speed of GSC migration. In contrast, GSCs do not tend to migrate toward the cortical area, which may be associated with complex and tight connections of neurons. These preferences in the direction of GCS migration may be related to a “butterfly” appearance of glioblastoma.
GSCs also displayed directional migration toward various directions, including the inferior horn of the lateral ventricle, that were independent of the axonal distributions. NPCs may be involved in the tropism of GSCs, because NPCs in the subventricular zone have been shown to secrete the neurite outgrowth-promoting factor pleiotrophin that is one of key chemoattractants for glioma invasion . Indeed, we observed many GSCs around GFAP-positive mouse cells located in the subventricular zone of the inferior horn but not in the body of the lateral ventricle.
The relationship between invasive migration and differentiation of GSCs has not been fully elucidated . We identified a few GFAP-positive astrocytes differentiated from hG008 GSCs only at the striatum around the implanted site. In contrast, GSCs invading the corpus callosum, striatum, and cortical area of the contralateral side were kept undifferentiated. Furthermore, GSCs at the contralateral side underwent cell division several times, indicating that the invasive GSCs maintained proliferative ability and did not undergo terminal differentiation. These results suggested that differentiation of GSCs after migration takes a certain amount of time, although the brain slice culture is of limited duration (~ 7 days).
Spatiotemporal visualization of GSC migration is informative. Our observations demonstrate various invasive characteristics of human hG008 GSCs, which share histological features observed in glioblastoma patients. Orthotopic xenografts of hG008 GSCs would serve as a good model to study GSC invasion and to evaluate possible therapies. Understanding the mechanisms underlying GSC invasion is essential for the development of effective therapy to inhibit diffuse infiltration. Spatiotemporal visualization techniques can be applied to other patient-derived GSCs in xenograft models and may be useful for patient-specific screening of anti-migration therapeutic agents.
Elongation factor 1 α subunit
Glioma stem cell
Neural progenitor cell
Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97–109.
Qazi MA, Vora P, Venugopal C, Sidhu SS, Moffat J, Swanton C, et al. Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma. Ann Oncol. 2017;28:1448–56.
Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987–96.
Cho RW, Clarke MF. Recent advances in cancer stem cells. Curr Opin Genet Dev. 2008;18:48–53.
Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, et al. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 2004;64:7011–21.
Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401.
Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, Hjelmeland AB, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006;444:756–60.
Osuka S, Sampetrean O, Shimizu T, Saga I, Onishi N, Sugihara E, et al. IGF1 receptor signaling regulated adaptive radioprotection in glioma stem cells. Stem Cells. 2013;31:627–40.
Vescovi AL, Galli R, Reynolds BA. Brain tumour stem cells. Nat Rev Cancer. 2006;6:425–36.
Ludwig K, Kornblum HI. Molecular markers in glioma. J Neuro-Oncol. 2017;134:505–12.
Miyai M, Tomita H, Soeda A, Yano H, Iwama T, Hara A. Current trends in mouse models of glioblastoma. J Neuro-Oncol. 2017;135:423–32.
Abernathey CD, Kooistra KL, Wilcox GL, Laws ER. New xenograft model for assessing experimental therapy of central nervous system tumors: human glioblastoma in the intrathecal compartment of the nude mouse. Neurosurgery. 1988;22:877–81.
Inoue S, Ichikawa T, Kurozumi K, Maruo T, Onishi M, Yoshida K, et al. Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas. World Neurosurg. 2012;78:670–82.
Notarangelo A, Trombetta D, D'Angelo V, Parrella P, Palumbo O, Storlazzi CT, et al. Establishment and genetic characterization of ANGM-CSS, a novel, immortal cell line derived from a human glioblastoma multiforme. Int J Oncol. 2014;44:717–24.
Strojnik T, Kavalar R, Lah TT. Experimental model and immunohistochemical analyses of U87 human glioblastoma cell xenografts in immunosuppressed rat brains. Anticancer Res. 2006;26:2887–900.
Joo KM, Kim J, Jin J, Kim M, Seol HJ, Muradov J, et al. Patient-specific orthotopic glioblastoma xenograft models recapitulate the histopathology and biology of human glioblastomas in situ. Cell Rep. 2013;3:260–73.
Wang J, Miletic H, Sakariassen PØ, Huszthy PC, Jacobsen H, Brekkå N, et al. A reproducible brain tumour model established from human glioblastoma biopsies. BMC Cancer. 2009;9:465.
Fukaya R, Ohta S, Yaguchi T, Matsuzaki Y, Sugihara E, Okano H, et al. MIF maintains the tumorigenic capacity of brain tumor-initiating cells by directly inhibiting p53. Cancer Res. 2016;76:2813–23.
Fayzullin A, Tuvnes FA, Skjellegrind HK, Behnan J, Mughal AA, Langmoen IA, et al. Time-lapse phenotyping of invasive glioma cells ex vivo reveals subtype-specific movement patterns guided by tumor core signaling. Exp Cell Res. 2016;349:199–213.
Jung S, Kim HW, Lee JH, Kang SS, Rhu HH, Jeong YI, et al. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J Cancer Res Clin Oncol. 2002;128:469–76.
Merz F, Gaunitz F, Dehghani F, Renner C, Meixensberger J, Gutenberg A, et al. Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments. Neuro-Oncology. 2013;15:670–81.
Naipal KA, Verkaik NS, Sánchez H, van Deurzen CH, den Bakker MA, Hoeijmakers JH, et al. Tumor slice culture system to assess drug response of primary breast cancer. BMC Cancer. 2016;9:78.
Yoshida D, Watanabe K, Noha M, Takahashi H, Teramoto A, Sugisaki Y. Anti-invasive effect of an anti-matrix metalloproteinase agent in a murine brain slice model using the serial monitoring of green fluorescent protein-labeled glioma cells. Neurosurgery. 2003;52:187–96.
Chung K, Wallace J, Kim SY, Kalyanasundaram S, Andalman AS, Davidson TJ, et al. Structural and molecular interrogation of intact biological systems. Nature. 2013;497:332–7.
Hama H, Kurokawa H, Kawano H, Ando R, Shimogori T, Noda H, et al. Scale: a chemical approach for fluorescence imaging and reconstruction of transparent mouse brain. Nat Neurosci. 2011;14:1481–8.
Hama H, Hioki H, Namiki K, Hoshida T, Kurokawa H, Ishidate F, et al. ScaleS: an optical clearing palette for biological imaging. Nat Neurosci. 2015;18:1518–29.
Susaki EA, Tainaka K, Perrin D, Kishino F, Tawara T, Watanabe TM, et al. Whole-brain imaging with single-cell resolution using chemical cocktails and computational analysis. Cell. 2014;157:726–39.
Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, Miyawaki A. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat Biotechnol. 2002;20:87–90.
Hara-Miyauchi C, Tsuji O, Hanyu A, Okada S, Yasuda A, Fukano T, et al. Bioluminescent system for dynamic imaging of cell and animal behavior. Biochem Biophys Res Commun. 2012;419:188–93.
Kokaia Z, Andsberg G, Martinez-Serrano A, Lindvall O. Focal cerebral ischemia in rats induces expression of P75 neurotrophin receptor in resistant striatal cholinergic neurons. Neuroscience. 1998;84:1113–25.
Beadle C, Assanah MC, Monzo P, Vallee R, Rosenfeld SS, Canoll P. The role of myosin II in glioma invasion of the brain. Mol Biol Cell. 2008;19:3357–68.
Petrie RJ, Yamada KM. Multiple mechanisms of 3D migration: the origins of plasticity. Curr Opin Cell Biol. 2016;42:7–12.
Zhong J, Paul A, Kellie SJ, O'Neill GM. Mesenchymal migration as a therapeutic target in glioblastoma. J Oncol. 2010;2010:430142.
Panková K, Rösel D, Novotný M, Brábek J. The molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells. Cell Mol Life Sci. 2010;67:63–71.
Cuddapah VA, Robel S, Watkins S, Sontheimer H. A neurocentric perspective on glioma invasion. Nat Rev Neurosci. 2014;15:455–65.
Winkler F, Kienast Y, Fuhrmann M, Von Baumgarten L, Burgold S, Mitteregger G, et al. Imaging glioma cell invasion in vivo reveals mechanisms of dissemination and peritumoral angiogenesis. Glia. 2009;57:1306–15.
Rubenstein BM, Kaufman LJ. The role of extracellular matrix in glioma invasion: a cellular Potts model approach. Biophys J. 2008;95:5661–80.
Aboitiz F, Scheibel AB, Fisher RS, Zaidel E. Fiber composition of the human corpus callosum. Brain Res. 1992;598:143–53.
Riise J, Pakkenberg B. Stereological estimation of the total number of myelinated callosal fibers in human subjects. J Anat. 2011;218:277–84.
Qin EY, Cooper DD, Abbott KL, Lennon J, Nagaraja S, Mackay A, et al. Neural precursor-derived pleiotrophin mediates subventricular zone invasion by glioma. Cell. 2017;170:845–59.
Kleihues P, Louis DN, Scheithauer BW, Rorke LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol. 2002;61:215–25.
The authors thank Dr. Chika Takao of the Department of Obstetrics and Gynecology for using the IVIS system and Hitoshi Miyagi and Miyuki Komura at OLYMPUS for technical assistance of laboratory works.
This work was supported in part by grants from the Japan Society for the Promotion of Science (JSPS) (16 K20026 to R.T., 18 K07301 to H. Miyoshi, 18 K19622 to M.T) and grants from the Japan Agency for Medical Research and Development (18bm0204001h0006 to H.O.).
Availability of data and materials
The datasets generated and/or analyzed during the current study are available from the corresponding author upon reasonable request.
All experiments were performed in accordance with the Guidelines for the Care and Use of Laboratory Animals of Keio University (Approval number: 14057) and the Guide for the Care and Use of Laboratory Animals (NIH).
Consent for publication
Written informed consent to publish was obtained from the patient.
H.O. is a compensated scientific consultant of San Bio, Co., Ltd. and K Pharma Inc. The other authors declare no potential conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Magnetic resonance imaging (MRI) of the patient from whom hG008 GSC line was derived. FLuid-Attenuated Inversion Recovery (FLAIR) images demonstrate the invasion into the corpus callosum. T1-weighted images with gadolinium (Gd) contrast enhancement demonstrate ring-enhanced lesion on the parietal lobe, which is typical image of glioblastoma. (PDF 98 kb)
About this article
Cite this article
Tamura, R., Miyoshi, H., Sampetrean, O. et al. Visualization of spatiotemporal dynamics of human glioma stem cell invasion. Mol Brain 12, 45 (2019). https://doi.org/10.1186/s13041-019-0462-3
- Glioma stem cell
- Brain slice culture
- Time-lapse imaging
- Tissue clearing